Oficiálny časopis Slovenskej kardiologickej spoločnosti,
Slovenskej hypertenziologickej spoločnosti a Slovenskej asociácie srdcových arytmií

Cardiology Letters 2024, 33(1):5-12

Komentár k Odporúčaniam ESC/ERS pre diagnózu a liečbu pµúcnej hypertenzie 2022

Iveta ©imková1, Bibiana Kafková2, Juraj Podracký2
1 Klinika kardiológie a angiológie LF SZU a NÚSCH, a. s., Bratislava, Slovenská republika
2 I. kardiologická klinika LF UPJ© a VÚSCH, a. s., Koąice, Slovenská republika

Uverejnené: January 1, 2024  Zobrazi» citáciu

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
©imková I, Kafková B, Podracký J. Komentár k Odporúčaniam ESC/ERS pre diagnózu a liečbu pµúcnej hypertenzie 2022. Cardiology Letters. 2024;33(1):5-12.
Stiahnu» citáciu

Referencie

  1. Humbert M, Kovacs G, Hoeper M, Badagliacca R, Berger RMF, Brida M, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2022;43:36183731. https://doi.org/10.1093/eurheartj/ehac237 Prejs» k pôvodnému zdroju...
  2. Rosenkranz S, Delcroix M, Giannakoulas G, Hoeper M, Kovacs G, Humbert M. The 'Ten Commandments' of the 2022 ESC/ ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Eur Heart J 2023 44:792-793. Prejs» k pôvodnému zdroju...
  3. Maron BA, Hess E, Maddox TM, Opotowsky AR, Tedford RJ, Lahm T, et al. Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study. Lancet Respir Med 2020;8:873-884. Prejs» k pôvodnému zdroju...
  4. Lichtblau M, Titz A, Bahrampoori B, Schmiedeskamp M, Ulrich S. What changed after the 2022 guidelines for pulmonary hypertension? Eur J Internal Med 2023, https://doi.org/10.1016/j.ejim.2023.08.021 Prejs» k pôvodnému zdroju...
  5. Grünig E, Benjamin N, Behr J, Skowasch D, Milger-Kneidinger K, Halank M, et al. The new European Guidelines for Pulmonary Hypertension with Updated Commentary of the PH-DACH Conference. A position paper of the German Society for Pneumology and Respiratory Medicine (DGP). Pneumologie 2023;77:852-853. Prejs» k pôvodnému zdroju...
  6. Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller G-P, et al. 2020 ESC Guidelines for the management of adult congenital heart disease. The Task Force for the Management of ACHD of the ESC. Eur Heart J 2020; doi:10.1093/eurheartj/ehaa554 Prejs» k pôvodnému zdroju...
  7. Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the ERS. Eur Heart J; 2019; doi/10.1093/eurheartj/ehz405. Prejs» k pôvodnému zdroju...
  8. Hoeper MM, Gomez Sanchez MA, Humbert M, Pittrow D, Simonneau G, Gall H, et al. Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry. Resp Medicine, 2020, DOI: https://doi.org/10.1016/j.rmed.2020.106241 Prejs» k pôvodnému zdroju...
  9. Jansa P, Kopeć G, Torbicki A, Sadushi-Kolici R, Campean JA, Halank M, Simkova I, et al. The risk profile change in patients with severe chronic thromboembolic pulmonary hypertension treated with subcutaneous treprostinil. Pulmonary Circulation, 2023;13:e12274, https://doi.org/10.1002/pul2.12274 Prejs» k pôvodnému zdroju...
  10. Guarino D, Ballerini A, Manes A. Commentary. What changed after the 2022 guidelines for pulmonary hypertension? Eur J Internal Med 2023, https://doi.org/10.1016/j.ejim.2023.08.021 Prejs» k pôvodnému zdroju...
  11. Humbert M, Sitbon O, Guignabert Ch, Savale L, Boucly A, GallantDewavrin M. Treatment of PAH: recent progress and look to the future. Lancet Respir Med 2023,11:804-819. Prejs» k pôvodnému zdroju...